In these studies, we compared the phenotype, function, and expression of type 1, type 2, and monocyte-associated cytokine mRNA transcripts in autologous bone marrow (BM) and growth factor-mobilized peripheral blood stem cell (PSC) products. These studies demonstrate that lymphocytes and monocytes in stem cell products are abnormally activated, expressing significantly higher levels of interleukin (IL)-2, 4 and 10, interferon gamma (IFN-␥), and tumor necrosis factor alpha (TNF-␣), but not IL-8, as compared to normal peripheral blood mononuclear cells (PBMC). In addition, the levels of IL-2, IL-10 and TNF-␣ are significantly higher in mobilized PSC as compared to BM products. The high cytokine levels are unexpected as T cell function in stem cell products is depressed. PSC products have high levels of T cell inhibitory activity, which directly correlates with IL-10 expression, both of which are mechanisms that might be involved in the immune dysfunction within stem cell products used for autologous stem cell transplantation. These data demonstrate that: (1) immune cells in autologous BM and PSC products are activated with the expression of high levels of type 1 and type 2 cytokines as well as monokines; (2) PSC products contain a high frequency of monocytes which mediate T cell inhibitory activity; and (3) despite the high levels of cytokine expression, T cell function in stem cell products is depressed. The significance of these immune abnormalities within stem cell products for myeloid and lymphoid recovery following autologous stem cell transplantation remains to be determined.
vations from our laboratory and others have demonstrated that there is a more rapid immunological reconstitution in patients receiving growth factor-mobilized PSCT as compared to BMT. [7] [8] [9] [10] [11] This might be due to the higher number of immune effector cells (lymphocytes and monocytes) infused by PSC as compared to BM products. 8, 12 In addition to the difference in the frequency and the number of infused T cells and monocytes in PSC and BM products, 12 ,13 the quantitative difference in the endogenous cytokine production in the different stem cell products and in the serum post-transplantation have been suggested to be important to lymphohematopoietic recovery. [14] [15] [16] [17] [18] Previous reports have also analyzed the role of immune cells in hematopoietic recovery and the expression of growth factors, such as stem cell factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and IL-6.
14 These studies investigated the serum levels of cytokines following transplantation [19] [20] [21] [22] with a focus on the endogenous levels of hematopoietic growth factors as related to hematological reconstitution. However, the expression of immunoregulatory cytokines in stem cell products including PSC and BM products has not been examined. Recent studies have reported in vitro cytokine production, both steady-state and induced, by mononuclear cells from the peripheral blood (PB) of allogeneic BM transplant patients post-transplantation and have shown defects in the production of IL-2, 23 ,24 IL-6 14 and IL-10.
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The two primary cellular components found within stem cell products are lymphocytes and monocytes. T lymphocytes express two distinct cytokine patterns. 25, 26 Type 1 cells produce IL-2 and IFN-␥, whereas type 2 cells produce IL-4, IL-5 and IL-10. The type 1 cytokines promote cellmediated responses while the type 2 cytokines promote immunoglobulin production and inhibit the differentiation of type 1 cells and cytokine release. [25] [26] [27] [28] [29] [30] In addition, type 2 cytokines can mediate immunosuppression. 31, 32 Similarly, monocytes produce IL-10, TNF-␣ and IL-12, which also modulate the immune response. 33 However, the differential expression of type 1, type 2 and monokine-specific mRNA transcripts and their role in the regulation of the immune function of mononuclear cells from stem cell products remains unclear.
In the present study, we analyzed the phenotype, function, and steady-state expression of cytokine genes in mononuclear cells from PSC and BM products as compared to normal PBMC and phytohemagglutinin (PHA)-stimulated normal PBMC using semi-quantitative reverse transcriptase-polymerase chain reactions (RT-PCR). T cell function was determined by PHA mitogenic response. In addition, we determined the presence of a cellular activity that can inhibit T cell function. The data demonstrate that both PSC and BM products express significantly higher levels of type 1 and type 2 cytokines as compared to normal PBMC. In addition, growth factor-mobilized PSC products express significantly higher levels of cytokine mRNA transcripts, including IL-2, IL-10 and TNF-␣ as compared to BM products. However, despite the high levels of cytokine gene expression, T cell function is significantly depressed in both stem cell products as compared to normal PBMC.
Materials and methods

Patients
Consecutive intermediate-grade non-Hodgkin's lymphoma (NHL) patients who were candidates for HDT and PSCT (n = 16, 10 males and six females, median age 52, range 21-68;) or BMT (n = 12, eight males and four females, median age 50, range 18-67) at the University of Nebraska Medical Center (UNMC) were entered into this study. Written informed consent for stem cell collection and autologous transplantation was obtained from each patient. All patients had received an average of four cycles of chemotherapy prior to HDT and stem cell transplantation. PSCT patients were mobilized with granulocyte colonystimulating factor (G-CSF) (10 g/kg/day) and a target dose of 6.5 × 10 8 mononuclear cells/kg body weight collected and cryopreserved. BM products were collected from the iliac crest using standard procedures. These samples were obtained using protocols approved by the Institutional Review Board of UNMC.
Mononuclear cell isolation
The fresh uncultured BM products from patients and PB from normal healthy donors (n = 10) were diluted 1:1 and the fresh uncultured PSC products from patients were diluted 1:2 in Hank's balanced salt solution (HBSS) (Gibco BRL, Grand Island, NY, USA) and isolated using FicollHypaque (Organon Teknika, Durham, NC, USA). Cells were then washed twice with HBSS and adjusted to 4 × 10 6 cells/ml in RPMI-1640 containing 10% fetal bovine serum (FBS), 10 mm HEPES, gentamycin, and l-glutamine.
Flow cytometric analysis
For phenotypic analysis, nucleated cells isolated from BM products, PSC products, and PB were obtained following erythrocyte lysis, counted, and adjusted to 1 × 10 6 cells in phosphate-buffered saline (PBS) (Gibco BRL) containing 2.5% FBS to maintain cell viability and processed according to the method described earlier. 8, 12, 13 Antibodies used in this study were FITC-labeled CD3, PE-labeled CD4, and biotin-labeled CD8 and CD14, purchased from Becton Dickinson (San Jose, CA, USA) and Coulter Corporation (Hialeah, FL, USA). All three-color data were acquired on a Becton Dickinson FACStar Plus flow cytometer. Detailed three-color data analysis was performed using the Attractors and CellQuest software from Becton Dickinson as described earlier.
8,12,13
Mitogen response
The mitogenic response of the mononuclear cells isolated from PSC and BM products as well as PB from normal donors were analyzed by methods described earlier. 8 Specific incorporation of 
T cell inhibitory activity assay
The methodology to measure T cell inhibitory activity present in the stem cell products and PBMC from normal donors has been described earlier. 8, 34 Briefly, 1 × 10 5 responder cells (freshly isolated normal Ficoll-Hypaque purified peripheral blood lymphocytes (PBL) ) were co-cultured with irradiated (5000 cGY) putative inhibitory cells (mononuclear cells isolated from BM products, PSC products, or PBMC from normal donors) at different inhibitorto-responder (I:R) ratios in medium containing an optimal concentration of PHA (0.5 g/ml). Responder cells alone, and putative inhibitory cells alone, were also incubated with medium alone or medium containing PHA (0.5 g/ml). Cells were cultured at 37°C and 5% CO 2 for 96 h. The mitogenic response of the responder population was assayed by pulsing with 1 Ci/well of 3 H-thymidine over the final 18 h of culture. Cells were harvested with a 96-well harvester onto fiberglass filters and the incorporation of 
Analysis of cytokine mRNA expression
Immediately following cell isolation, total cellular RNA was isolated from PSC, BM products, or PBMC using Trizol reagent (Gibco BRL, Gaithersburg, MD, USA). 35 Firststrand cDNA was synthesized by reverse transcribing 2 g of total RNA using superscript RT (Gibco) according to the manufacturer's protocol. Two microliters of a 1:10 dilution of first-strand cDNA were added to 5 l of 10 × PCR buffer (Gibco BRL), 1 l of dNTP mix (10 mm each of dTTP, dATP, dCTP and dGTP), 1.5 l of 50 mm MgCl 2 , and 0.25 l of Taq DNA polymerase (Gibco). Two and a half microliters of each primer (10 m each) were added to give a final primer concentration of 0.5 m and the total volume was adjusted to 50 l with sterile dH 2 O. The mixture was subjected to DNA amplification using a DNA thermal cycler (Perkin Elmer, Foster City, CA, USA) set at different annealing temperatures (55°C for ␤-actin, IL-4, IL-10, TNF-␣ and IL-8, and 50°C for IL-2 and IFN-␥) for a total of 20 cycles for ␤-actin and 40 cycles for the other genes. PCR fragments were separated on 2% agarose gel in TAE buffer containing 0.25 g/ml ethidium bromide, visualized and photographed using UV trans-illuminator (Kodak, Rochester, NY, USA). For quantitative analysis and to confirm the specificity of the amplified sequences, gels were processed for Southern blot analysis. Oligonucleotide primers (Table 1) were designed based on the published sequences with 5Ј primers (+ strand) and 3Ј primers (Ϫ strand) and flanked by a single intron so that any amplification of contaminating genomic DNA would be readily identified. The specificity of the product was verified by blotting the fragments onto nylon membranes and probing with specific oligonucleotide sequences and analyzing using digital autoradiography (Phosphor Imager; Molecular Dynamics, Sunnyvale, CA, USA). Relative levels of radioactivity between samples were determined using Image Quant software on the Phosphor Imager. Relative mRNA transcript levels were obtained using equal number of cells with simultaneous amplification in the linear range (see Figure 1 ). Results were not used if the housekeeping gene signals between groups were undetectable in a given sample/experiment. Cytokine signals are expressed as expression index calculated by comparing the ratio of each cytokine signal to the signal from the housekeeping gene ␤-actin. Table 1 Primers used for RT-PCR analysis 
Cytokine Primers
IL
Enzyme linked immunosorbant assay (ELISA)
The secretory levels of the different cytokines were analyzed using an ELISA. Primary antibodies and biotinylated secondary antibodies were purchased from Endogen (Philadelphia, PA, USA) (IL-4, IL-10, IFN-␥) and R&D Corporation (Minneapolis, MN, USA) (IL-2). Cytokines were measured in culture supernatant following a 24 h incubation of 1 × 10 5 cells/well with 0.5 g/ml PHA or without PHA. Culture supernatants were collected and analyzed by ELISA. First, 100 l of primary antibodies (2 g/ml) were coated on Immunolon plates (Dynatech Laboratories, Chantilly, VA, USA), followed by a blocking buffer (PBS/4% BSA). Fifty microliters of either standard (at different dilutions) or test samples and 50 l of biotinylated anticytokine antibody were added to each well and incubated for 2 h. Plates were washed with a washing buffer (50 mm Tris/0.2% Tween) and 100 l of a 1:8000 dilution of avidin-conjugated HRP (Dako Laboratories, Carpinteria, CA, USA) added to each well. After 30 min, plates were washed and 100 l of TMB substrate were added to each well and incubated for 30 min. Reactions were stopped by addition of 100 l of 0.18 m H 2 SO 4 and the absorbency was determined at 450 nm. Standard plots were prepared and the concentration of the unknowns was determined.
Statistical analysis
SPSS for Windows (SPSS, Chicago, IL, USA) was used for the independent samples t-test (two-tailed) to compare means, and the correlation analysis was performed using Pearson's analysis. The data presented are a composite of all the patients analyzed in each group.
Results
Immune cells in PSC and BM products
The cellular phenotypes (T cells: CD3 + , CD4 + or CD8 + cells (low side scatter and high expression of CD3, CD4 and CD8), and monocytes (intermediate side scatter and high expression of CD14)) in growth factor-mobilized PSC and BM products from NHL patients and PB from normal healthy donors (control) were determined using flow cytometry as described earlier. 8, [12] [13] [14] The frequency of CD3 + , CD4
+ and CD8 + cells was significantly higher in PSC products as compared to BM products (all P р 0.01), but were similar to normal PB (Figure 2a, b and c) . In contrast, the frequency of CD3 + , CD4 + and CD8 + cells was significantly lower in BM products as compared to normal PB (P = 0.05) (Figure 2a, b and c) . The frequency of CD14 + monocytes also was significantly higher in PSC products as compared to BM (P р 0.001) and normal PB (P р 0.001) (Figure 2d ).
Immune functions of BM and PSC products
The T cell mitogenic activity of the BM and PSC products was analyzed by determining their proliferative response to PHA and expressed as a SI, as described earlier. 8, 12, 34 Normal PBMC were used as a baseline control in these studies, and the results are shown in Figure 3 . In these studies, the PHA mitogenic response of the mononuclear cells from PSC products was significantly higher compared to the mononuclear cells from BM products. However, the T cell mitogenic response in both BM and PSC products was significantly lower as compared to normal PBMC, suggesting a depressed immune function. Interestingly, the baseline levels of proliferation in the PSC and BM products were higher as compared to normal PBMC (c.p.m. in untreated cultures: PSC products, 1183 Ϯ 1876; BM, 12 871 Ϯ 1614; and normal PBMC, 686 Ϯ 32). Nonetheless, the response to optimal concentrations of PHA (0.5 g/ml) in PSC (11 915 Ϯ 1916) and BM products (16 757 Ϯ 2254) was significantly lower than that of normal PBMC (173 080 Ϯ 3439), leading to a decreased S.I. in BM (1.6 Ϯ 0.3) and PSC (13.6 Ϯ 1.7) products compared to normal PBMC (286.6 Ϯ 2.9).
To understand the mechanism of immune dysfunction, we measured cellular T cell inhibitory activities in BM and PSC products by examining the ability of irradiated cells to inhibit the mitogenic response of allogeneic PBMC to PHA. 8, [12] [13] [14] A significantly higher level of T cell inhibitory activity was observed in PSC products (P р 0.001) as compared to BM products and normal PBMC ( Table 2 ). Similar to our earlier observation, 34 the T cell inhibitory activity was dependent upon the I:R ratios ( Table 2) .
Expression of cytokine genes in BM and PSC products
The relative abundance of specific mRNA transcripts for type 1 (IL-2, IFN-␥), and type 2 (IL-4, IL-10) cytokines and monokines (TNF-␣ and IL-8) were analyzed by RT-PCR in BM and PSC products and compared to normal steady-state and PHA-stimulated PBMC (results are shown in Figures 4-6 as an average expression index Ϯ standard error of the mean (EI Ϯ s.e.m) ). IL-2 mRNA transcripts in PSC products (0.721 Ϯ 0.000729) were significantly higher (P = 0.006; 44-fold increase) than in BM products (0.0163 Ϯ 0.000108). Furthermore, the levels of IL-2 mRNA transcripts were significantly higher in both BM (144-fold) and PSC products (638-fold) as compared to normal PBMC (0.000113 Ϯ 0.0000124; both P р 0.001). However, the IL-2 mRNA levels in PSC products were similar to PHA activated PBMC (0.6531 Ϯ 0.047) (Figure 4a) . Similarly, IFN-␥ mRNA expression in both BM (0.3953 Table 2 Monocyte-dependent T cell inhibitory activity in stem cell products Ϯ 0.0283) and PSC products (1.2231 Ϯ 0.1473) was significantly higher (96.6-fold in BM and 299-fold higher in PSC products; P = 0.001 and P = 0.0003, respectively) compared to normal PBMC (0.00409 Ϯ 0.00005) and was similar to the PHA-activated PBMC (0.5642 Ϯ 0.0406) (Figure 4b ). The expression of IL-10 and IL-4 mRNA also was studied. PSC products (5.5095 Ϯ 1.3573) expressed significantly higher levels of IL-10-specific mRNA transcripts (9.4-fold; P = 0.05) as compared to BM products (0.5828 Ϯ 0.1784), which were similar to PHA-stimulated PBMC (6.4539 Ϯ 3.3120) ( Figure  5b ). In addition, the IL-10 mRNA levels in both BM (15.5-fold) and PSC products (163-fold) were significantly higher (P = 0.003 and P = 0.0001, respectively) as compared to normal PBMC (0.0337 Ϯ 0.0119). In contrast, the levels of IL-4-spe- cific mRNA transcripts were not significantly different between the PSC (0.3665 Ϯ 0.178) and BM products (0.130 Ϯ 0.031) (Figure 5a ). However, both BM (68.4-fold) and PSC (192-fold) products expressed significantly higher levels (P р 0.001 and P р 0.0001, respectively) of IL-4-specific mRNA transcripts as compared to normal PBMC (0.0019 Ϯ 0.0004) and PHAactivated PBMC (0.0051 Ϯ 0.0018) (Figure 5a ). These data suggest that PSC and BM products have a mixed type 1 and type 2 pattern of cytokine gene expression. Furthermore, both PSC and BM products express higher levels of all cytokine mRNA transcripts analyzed as compared to normal PBMC, suggesting that these products may contain activated lymphocytes (Figures 4 and 5) . We also determined the expression of two monokines, IL-8 and TNF-␣, in PSC and BM products ( Figure 6 ). The levels of TNF-␣ gene expression in PSC (0.537 Ϯ 0.01272) products were significantly higher (2.6-fold) as compared to BM products (0.2062 Ϯ 0.0350 (P = 0.05) ) and were similar to PHA-activated PBMC (1.0262 Ϯ 0.214). Both BM (13.3-fold) and PSC (34.8-fold) products expressed significantly higher levels of TNF-␣ mRNA transcripts as compared to normal PBMC (0.0154 Ϯ 0.0043 (P = 0.005 and P = 0.001, respectively) ) (Figure 6a ). In contrast, there were no significant differences in the levels of IL-8 gene expression in PSC (0.5932 Ϯ 0.3369) and BM products (0.2354 Ϯ 0.1286) (Figure 6b) . Furthermore, the levels of IL-8-specific mRNA transcripts in PSC and BM products were significantly lower as compared to the steady-state PBMC (1.9439 Ϯ 0.3338 (P = 0.05 and P = 0.01, respectively) ) and PHA-activated PBMC (28.5871 Ϯ 5.884 (P = 0.001 and P = 0.003) ) (Figure 6b) .
In other studies, we analyzed the secreted levels of the type 1 and type 2 cytokines in PSC products and compared them with normal PBMC and PHA-activated PBMC and PSC products. Similar to the mRNA levels, the secretion of both type 1-and type 2-associated cytokines in PSC products was significantly higher compared to normal PBMC (Figure 7 ). After activation with PHA, there were significantly higher levels of secreted IL-2, IL-4, IL-10, and IFN-␥ in the culture supernates of normal PBMC. However, PHA treatment increased the IL-2 and IFN-␥, but not IL-4 and IL-10 protein secretion by PSC products (Figure 7a) . Furthermore, in a limited number of PSC (n = 6) and normal PBMC (n = 4) samples, treated or untreated with PHA, we analyzed mRNA expression by RT-PCR and protein secretion by ELISA. In these studies, Pearson's correlation analysis revealed a direct correlation between cytokine mRNA levels and protein secretion (r = 0.403, P р 0.001) (Figure 8) .
Correlation of cytokine genes expression, immune phenotype and function
The PHA mitogenic response directly correlated with the frequency of T cells (CD3 + cells, r = 0.586, P = 0.001) in stem cell products ( Figure 9 ). In addition, there was a direct correlation between T cell inhibitory activity and IL-10 mRNA levels (r = 0.473; P = 0.026) ( Figure 9 ).
Discussion
In the present study we analyzed the phenotype, function, and expression of type 1, type 2, and monocyte-associated cytokine mRNA transcripts in autologous BM and growth factor-mobilized PSC products as compared to steady-state and PHA-activated normal PBMC. The expression of all the cytokines analyzed, except IL-8, was significantly higher in both BM and PSC products as compared to normal PBMC, and similar to PHA-activated PBMC. In contrast, the T cell mitogenic function in both products was significantly depressed as compared to normal PBMC. In PSC products, this was not due to a change in T cell frequency as it was similar to normal PBMC. The PSC products demonstrated a higher mitogenic response (stimulation index) to PHA as compared to BM products, which might be due to the higher frequency of T cells and/or higher levels of cytokine gene expression. However, lymphocyte function was significantly decreased in both stem cell products as compared to steady-state PBMC. Similar to our earlier studies, 34 the present data demonstrated significantly higher levels of cellular T cell inhibi- tory activity in PSC products as compared to both BM products and steady-state normal PBMC.
Studies on immunological reconstitution after BMT and PSCT have demonstrated a marked depression in immune function. 8, 9, 12, 38, 39 These studies suggest a significant role for accessory cells (mainly monocytes) in the recovery of immunologic function. [14] [15] [16] Patients receiving steady-state BM products that have a reduced frequency of accessory cells have a marginally slower immune reconstitution than those receiving an intact-mobilized PSC product, suggesting the role of these cells in immune recovery. [14] [15] [16] These data also indicate that so-called accessory cells (mainly lymphocytes and monocytes) do not make a major contribution to hematological recovery, but might play an important role in immunological reconstitution. [14] [15] [16] 36, 37 Interestingly, none of the studies, to date, have examined the role of cytokine gene expression on immunologic recovery. A defect in cytokine production was reported following stem cell transplantation for solid tumors and hematological malignancies regardless of BM or PSC origin.
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Previous reports have also analyzed the role of immune cells in hematopoietic reconstitution and the expression of stem cell factor, GM-CSF and IL-6. 14, 17, 18 These studies investigated the serum levels of cytokines following transplantation 19, 20 with a focus on the endogenous levels of hematopoietic growth factors as related to hematological reconstitution. To date, all of the studies examining in vitro cytokine production, both steady-state and induced, have been undertaken using the PBMC of allogeneic BM transplant patients 40 and have shown defects in the production of IL-2, 23,24 IL-6 14 and IL-10. 11 The present study represents the first detailed study of cytokine gene expression in BM and growth factor-mobilized PSC products used for autologous stem cell transplantation. To increase the sensitivity of detection and limit the required sample size, we employed semi-quantitative RT-PCR analysis for these studies. Confirmation of these results using the analysis of cytokines at the protein level demonstrated that mononuclear cells from PSC products secreted higher levels of both type 1-and type 2-associated cytokines as compared to mononuclear cells from normal PBMC. Furthermore, we observed an association between the expression of cytokine mRNA levels and protein secretion.
The high levels of IL-4 and IL-10 mRNA transcripts in both BM and PSC products may contribute to the immune dysfunction observed post-transplant. Furthermore, the expression of high levels of IL-10 and TNF-␣ in PSC as compared to BM products might be associated with the increased frequency of monocytes and the high levels of T cell inhibitory activity in the PSC products. These studies suggest a correlation between the expression of IL-10 and T cell inhibitory activity within stem cell products. A recent report suggested that IFN-␥ and TNF-␣ may be directly involved in the inhibition of T cell functions. 41 In this study antibodies directed against TNF-␣ and IFN-␥ abolished the T cell inhibitory activity in a synergistic manner. Recent preliminary data from our laboratory suggest the involvement of Fas-Fas ligand interaction in monocyte-dependent T cell inhibitory activity. 42 Additional studies are in progress to analyze the expression of cytokine genes in isolated subpopulations of immune cells (CD4 + , CD8 + and CD14 + cells) and to determine their role in immunologic reconstitution following stem cell transplantation. In addition, future studies need to examine the role of cytokine expression in the stem cell product on immune recovery. In summary, significantly different patterns of cytokine gene expression, cellular phenotype, and function occur in the PSC and BM products. The data suggest that PSC products contain activated T cells whose function is suppressed by the high frequency of activated monocytes. 34 In BM products, the immune cells are also activated; however, the lower frequency of T cells as compared to normal PB may be the source of the lower immune function.
